ReviewJournal for immunotherapy of cancer2022

Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment.

Dali TongPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.